HOUSE_OVERSIGHT_024101.jpg
1.22 MB
Extraction Summary
0
People
24
Organizations
0
Locations
0
Events
1
Relationships
3
Quotes
Document Information
Type:
Financial investment schedule / appendix
File Size:
1.22 MB
Summary
This document is a confidential financial appendix detailing the investment portfolio of New Leaf Ventures I, L.P. as of March 31, 2014. It lists specific realized and unrealized investments in healthcare and therapeutics companies, providing data on vintage years, costs, values, and gross internal rates of return (IRR). The document is marked with a House Oversight control number, suggesting it is part of a larger investigation, likely involving financial scrutiny.
Organizations (24)
| Name | Type | Context |
|---|---|---|
| New Leaf Ventures I, L.P. | ||
| Aesthetic Sciences Corporation | ||
| Artisan Pharma, Inc. | ||
| Aviir, Inc. | ||
| Barrier Therapeutics, Inc. | ||
| BioRelix, Inc. | ||
| Cerexa, Inc. | ||
| CN Therapeutics, Inc. | ||
| Interlace Medical, Inc. | ||
| Oriel Therapeutics, Inc. | ||
| Pearl Therapeutics, Inc. | ||
| Proteogenix, Inc. | ||
| Stromedix, Inc. | ||
| Transcept Pharmaceuticals, Inc | ||
| Access Closure, Inc. | ||
| Concert Pharmaceuticals, Inc. | ||
| Direct Flow Medical, Inc. | ||
| IlluminOss Medical, Inc. | ||
| Intarcia Therapeutics, Inc. | ||
| Relypsa, Inc. | ||
| ReShape Medical | ||
| Tioga Pharmaceuticals, Inc. | ||
| VaxInnate, Inc. | ||
| House Oversight Committee |
Relationships (1)
Table lists New Leaf Ventures I, L.P. investments in companies such as Intarcia Therapeutics, Pearl Therapeutics, etc.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein document